Clinical trials endpoint taxonomy

Invalid Reason: Trial flagged as non-clinical, duplicate, or administrative error.

No Context: "Stopped", "Terminated" without further explanation.

Study Design: Protocol flaws, feasibility issues, or design amendments required.

Logistics or Resources: Drug supply shortage, manufacturing failure, or lack of facilities.

Study Staff Moved: Departure of Principal Investigator (PI) or key personnel.

Insufficient Enrolment: Slow accrual, lack of eligible patients.

Insufficient Data: Stopped early without enough data to form a conclusion.

Interim Analysis: Stopped based on pre-planned statistical thresholds (neutral).

Business or Administrative: Sponsor decision, prioritization, funding, or strategic reasons (High Ambiguity).

Another Study: External results (competitor or new standard of care) made this trial obsolete.

Covid 19: Stopped directly due to pandemic disruptions.

Regulatory: FDA/EMA clinical hold or regulatory mandate.

Ethical Reason: IRB/Ethics committee decision unrelated to safety (e.g., consent issues).

Safety and Side Effects: Toxicity, adverse events, or harm to participants.

Negative: Lack of efficacy, futility, or risk-benefit ratio no longer favorable.

Endpoint Met: Stopped early for overwhelming efficacy (Positive).

Success: Trial completed its objectives early (General Positive).